Contact Allergy to Methacrylate Containing Nail Products: Lack of Impact of EU Legislation. An Audit on Behalf of the European Environmental Contact Dermatitis Research Group (EECDRG)

Fuente: Wiley Open Access
Saved in:
Bibliographic Details
Main Authors: S. Mark Wilkinson, Olivier Aerts, Tove Agner, Magnus Bruze, Richard Brans, Caterina Foti, Ana Maria Giménez‐Arnau, Luca Stingeni, Cecilia Svedman
Format: Artículo Open Access
Published: Wiley 2024
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867019567225634816
author S. Mark Wilkinson
Olivier Aerts
Tove Agner
Magnus Bruze
Richard Brans
Caterina Foti
Ana Maria Giménez‐Arnau
Luca Stingeni
Cecilia Svedman
author_facet S. Mark Wilkinson
Olivier Aerts
Tove Agner
Magnus Bruze
Richard Brans
Caterina Foti
Ana Maria Giménez‐Arnau
Luca Stingeni
Cecilia Svedman
S. Mark Wilkinson
Olivier Aerts
Tove Agner
Magnus Bruze
Richard Brans
Caterina Foti
Ana Maria Giménez‐Arnau
Luca Stingeni
Cecilia Svedman
collection Wiley Open Access
contents Contact Allergy to Methacrylate Containing Nail Products: Lack of Impact of EU Legislation. An Audit on Behalf of the European Environmental Contact Dermatitis Research Group (EECDRG) S. Mark Wilkinson Olivier Aerts Tove Agner Magnus Bruze Richard Brans Caterina Foti Ana Maria Giménez‐Arnau Luca Stingeni Cecilia Svedman Contact Dermatitis ABSTRACTBackgroundThere is a current fashion for the use of methacrylate‐containing nail cosmetics that can induce allergic contact dermatitis. European Union (EU) legislation was introduced in 2021 that had the aim of preventing its development.ObjectivesTo assess prevalence and exposures causing contact allergy to 2‐hydroxyethyl methacrylate (HEMA) prior to and following implementation of the legislation.MethodsA retrospective audit was conducted by 7 European centres patch testing to HEMA prior to the legislation and for 2 years afterwards.ResultsA total of 26 297 patients were tested to HEMA in the baseline series between 2016 and 2023. The prevalence of contact allergy to HEMA from all sources amongst females was 2.82% compared to 0.34% amongst males.The prevalence of nail related contact allergy rose from 0.91% in 2016 (2 centres) to: 0.99% in 2017 (3 centres); 1.24% in 2018 (5 centres); 1.23% in 2019 (6 centres); 1.36% in 2020 (7 centres); 1.30% in 2021 (7 centres); 1.52% in 2022 (7 centres) and 1.98% in 2023 (7 centres).Contact allergy to HEMA from exposure to nail cosmetics accounted for 3.4% of all occupational skin disease.ConclusionsEU legislation appears not to have had the intended impact on controlling allergic contact dermatitis from methacrylates in nail cosmetics. There is an urgent need to revisit Scientific Committee on Consumer Safety (SCCS) opinion to reconsider exposure to methacrylates and cross‐reactions between them. A strategy needs to be developed and implemented to better control the current outbreak. 10.1111/cod.14745 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1111/cod.14745
format Artículo Open Access
id wiley_oa_10_1111_cod_14745
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Contact Allergy to Methacrylate Containing Nail Products: Lack of Impact of EU Legislation. An Audit on Behalf of the European Environmental Contact Dermatitis Research Group (EECDRG)
S. Mark Wilkinson
Olivier Aerts
Tove Agner
Magnus Bruze
Richard Brans
Caterina Foti
Ana Maria Giménez‐Arnau
Luca Stingeni
Cecilia Svedman
Contact Dermatitis
Contact Allergy to Methacrylate Containing Nail Products: Lack of Impact of EU Legislation. An Audit on Behalf of the European Environmental Contact Dermatitis Research Group (EECDRG) S. Mark Wilkinson Olivier Aerts Tove Agner Magnus Bruze Richard Brans Caterina Foti Ana Maria Giménez‐Arnau Luca Stingeni Cecilia Svedman Contact Dermatitis ABSTRACTBackgroundThere is a current fashion for the use of methacrylate‐containing nail cosmetics that can induce allergic contact dermatitis. European Union (EU) legislation was introduced in 2021 that had the aim of preventing its development.ObjectivesTo assess prevalence and exposures causing contact allergy to 2‐hydroxyethyl methacrylate (HEMA) prior to and following implementation of the legislation.MethodsA retrospective audit was conducted by 7 European centres patch testing to HEMA prior to the legislation and for 2 years afterwards.ResultsA total of 26 297 patients were tested to HEMA in the baseline series between 2016 and 2023. The prevalence of contact allergy to HEMA from all sources amongst females was 2.82% compared to 0.34% amongst males.The prevalence of nail related contact allergy rose from 0.91% in 2016 (2 centres) to: 0.99% in 2017 (3 centres); 1.24% in 2018 (5 centres); 1.23% in 2019 (6 centres); 1.36% in 2020 (7 centres); 1.30% in 2021 (7 centres); 1.52% in 2022 (7 centres) and 1.98% in 2023 (7 centres).Contact allergy to HEMA from exposure to nail cosmetics accounted for 3.4% of all occupational skin disease.ConclusionsEU legislation appears not to have had the intended impact on controlling allergic contact dermatitis from methacrylates in nail cosmetics. There is an urgent need to revisit Scientific Committee on Consumer Safety (SCCS) opinion to reconsider exposure to methacrylates and cross‐reactions between them. A strategy needs to be developed and implemented to better control the current outbreak. 10.1111/cod.14745 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Contact Allergy to Methacrylate Containing Nail Products: Lack of Impact of EU Legislation. An Audit on Behalf of the European Environmental Contact Dermatitis Research Group (EECDRG)
topic Contact Dermatitis
url https://onlinelibrary.wiley.com/doi/10.1111/cod.14745